Clinical trial
A Study of Infliximab in Patients With Sarcoidosis
NCT00073437 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00073437 |
|---|---|
| Title | A Study of Infliximab in Patients With Sarcoidosis |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Infliximab (Remicade) in Subjects With Chronic Sarcoidosis With Pulmonary Involvement. |
| Lead sponsor | Centocor, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoidosis |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 139 |
| Start date | Oct 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | Nov 24, 2003 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: